- 4.4Impact Factor
- 8.8CiteScore
- 20 daysTime to First Decision
Therapy in Gastrointestinal Oncology
This special issue belongs to the section “Cancer Therapy“.
Special Issue Information
Dear Colleagues,
Our understanding of the biology of cancer has grown rapidly over the last decade, leading to advances in new types of targeted therapies and novel therapeutic approaches.
This Special Issue will discuss recent advances in minimally invasive treatment for GI oncology; endoscopic therapy for early GI cancers; surgical management (including techniques and considerations for minimally invasive approaches); and innovations in neoadjuvant and adjuvant chemotherapy, immunotherapy, and radiation treatment for GI cancers. This Special Issue will also discuss the roles of the novel therapies, including rational and structure-based drug design, that are currently being pursued in the clinical setting and hold the promise of improving the clinical outcome of these conditions.
Dr. Saowanee Ngamruengphong
Assoc. Prof. Fabian M. Johnston
Assoc. Prof. Lei Zheng
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Cancer therapy
- Genetics and genomics of cancer
- Immunotherapy for GI cancer
- Microbiome and gastric cancer
- Molecularly targeted therapies for GI cancer
- Therapeutic approaches to GI cancer
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

